Carson Wealth (CWM LLC)
RYTM icon

Carson Wealth (CWM LLC)’s Rhythm Pharmaceuticals RYTM Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$221K Sell
2,536
-231
-8% -$22.5K ﹤0.01% 2657
2025
Q4 		$296K Sell
2,767
-125
-4% -$13.3K ﹤0.01% 2268
2025
Q3 		$292K Sell
2,892
-199
-6% -$18.5K ﹤0.01% 2160
2025
Q2 		$195K Buy
3,091
+507
+20% +$31K ﹤0.01% 2201
2025
Q1 		$137K Buy
2,584
+1,240
+92% +$68.8K ﹤0.01% 2170
2024
Q4 		$75K Buy
1,344
+417
+45% +$23K ﹤0.01% 2479
2024
Q3 		$49K Buy
927
+270
+41% +$12.9K ﹤0.01% 2709
2024
Q2 		$27K Buy
657
+253
+63% +$10.1K ﹤0.01% 2925
2024
Q1 		$18K Buy
404
+197
+95% +$8.62K ﹤0.01% 2982
2023
Q4 		$10K Hold
207
– – ﹤0.01% 3201
2023
Q3 		$5K Buy
207
+7
+4% +$157 ﹤0.01% 3486
2023
Q2 		$3K Hold
200
– – ﹤0.01% 3686
2023
Q1 		$4K Hold
200
– – ﹤0.01% 3421
2022
Q4 		$6K Hold
200
– – ﹤0.01% 3109
2022
Q3 		$5K Hold
200
– – ﹤0.01% 3098
2022
Q2 		$1K Sell
200
-66
-25% -$361 ﹤0.01% 3624
2022
Q1 		$3K Buy
266
+66
+33% +$579 ﹤0.01% 3078
2021
Q4 		$2K Buy
+200
New +$2.25K ﹤0.01% 3175

Other funds holding RYTM

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Carson Wealth (CWM LLC)'s RYTM Position: Q1 2026 in Review

Carson Wealth (CWM LLC) reduced its Rhythm Pharmaceuticals (RYTM) stake by 8.3% in Q1 2026, selling an estimated $22.5K and leaving 2,536 shares worth $221K. The position accounts for ﹤0.01% of the portfolio, ranked #2657.

Carson Wealth (CWM LLC) first reported a position in RYTM in Q4 2021 and has held it in 18 quarters since. The position peaked at $296K in Q4 2025. 285 funds tracked by Wall St. Rank hold RYTM as of Q1 2026.

  • Carson Wealth (CWM LLC) held 2,536 shares of Rhythm Pharmaceuticals worth $221K as of Q1 2026.
  • Carson Wealth (CWM LLC) sold 231 Rhythm Pharmaceuticals shares in Q1 2026, an estimated $22.5K.
  • Rhythm Pharmaceuticals made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #2657 holding.
  • Carson Wealth (CWM LLC) first reported a position in Rhythm Pharmaceuticals in Q4 2021 and has held it in 18 quarters since.
  • Carson Wealth (CWM LLC)'s Rhythm Pharmaceuticals position peaked at $296K in Q4 2025.
  • 285 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.